Connect with us

Medical

FDA Public Meeting: Identification of Concepts and Terminology for Multi-Component Biomarkers – 03/23/2022

Claudia Baldwin

Published

on

The FDA Center for Drug Evaluation and Research and the FDA Biomarker Working Group will convene a virtual workshop on March 23-24, 1-3 PM (EST) entitled “Identification of Concepts and Terminology for Multi-Component Biomarkers”. The workshop is intended to develop multi-component biomarker concepts and terminology to identify areas of conceptual

Original Source: fda.gov

Medical

FDA Approves Neoadjuvant Nivolumab and Platinum-doublet Chemotherapy for Early-stage Non-small Cell Lung Cancer

Claudia Baldwin

Published

on

By

FDA approves neoadjuvant nivolumab and platinum-doublet chemotherapy for early-stage non-small cell lung cancer

Original Article: fda.gov

Continue Reading

Medical

Data Standards Program Strategic Plan and Board

Claudia Baldwin

Published

on

By

The Data Standards Strategy reinforces CDER’s ongoing commitment to the development, implementation, and maintenance of a comprehensive data standards program that will facilitate the efficient and effective review of regulatory submissions. This helps bring safe and effective products to market.

Original Source: fda.gov

Continue Reading

Medical

CTTI and FDA Public Workshop on Enhancing the Incorporation of Patient Perspectives in Clinical Trials – 03/18/2019

Claudia Baldwin

Published

on

By

On March 18, 2019, the Clinical Trials Transformation Initiative (CTTI) and FDA held a public workshop, “Enhancing the Incorporation of Patient Perspectives in Clinical Trials.” This workshop met an FDA commitment that is part of the sixth authorization of PDUFA VI.

Original Post: fda.gov

Continue Reading

Trending

WVPU.com